Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma
Clinical trial NCT00277017 · COMPLETED
Trial details
- NCT number
- NCT00277017
- Sponsor
- New Mexico Cancer Research Alliance
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Primary completion
- 2005-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.